Phagestaph (20ml x 4) is used for treatment and prevention of purulent-inflammatory diseases caused by Staphylococcus aureus (including MRSA - Multi-resistant Staphylococcus aureus).
Theurapeutic Indications: Preparation is used for the treatment and prevention of bacterial purulent-inflammatory infections, caused by Staphylococcus aureus in all ages and high risk groups:
Surgery: purulent wound, burns, abscess, phlegmon, furuncles, carbuncles, hidradenitis, panaritium, paraproctitis, mastitis, bursitis, osteomyelitis;
Urology:urogenital infections: urethritis, cystitis, pyelonephritis, colpitis, endometritis, salpingo-oophoritis;
Gastroenterology: enterocolitis, cholecystitis, Irritable bowel syndrome (IBS-dysbiosis);
Bacterial infections of the upper and lower respiratory tract, inflammation of the sinuses, otisis media, tonsillitis, pharyngitis, laryngitis, tracheitis, bronchitis, pneumonia, pleuritis.
For detailed product information, annotation and registration certificate please visit the following page:
https://biochimpharm.ge/en/product/phagestaph-4x-20ml/